Pay in 4 interest-free payments of $5.44 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
This compound is typically supplied in a lyophilized (freeze-dried) format, which supports product stability and allows for extended storage when handled under proper laboratory conditions
Dure de conservation longue : Dure de conservation de 2 ans lorsqu'il est stock dans un rcipient hermtiquement ferm
Safety Information Published laboratory and cosmetic research generally reports favorable tolerability under investigated conditions
Performance cycle (10 mg/week for 8 weeks): 80 mg total, requiring 8 vials
Ipamorelin amplifies each pulse Tesamorelin (Egrifta) Mimics natural GHRH to trigger pituitary GH release Clinical Data CJC-1295/Ipamorelin Phase 2 (CJC-1295), preclinical + Phase 2 (Ipamorelin) Tesamorelin (Egrifta) Two Phase 3 RCTs, 816 patients Approved Indication CJC-1295/Ipamorelin None (compounded) Tesamorelin (Egrifta) HIV-associated lipodystrophy Availability CJC-1295/Ipamorelin Compounding pharmacy with prescription Tesamorelin (Egrifta) Compounding pharmacy with prescription (also as branded Egrifta) PeRx Offers Both PeRx prescribes both CJC-1295/Ipamorelin and Tesamorelin
US$ 27.43
US$ 24.90
US$ 25.73
US$ 26.95
US$ 29.58
US$ 26.43
US$ 25.78
US$ 23.73
